Skip to main content

Find Clinical Trials

Home
Conditions
Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection

Clinical trial condition

Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection

Explore clinical trials studying Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection trial results

Completed

An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications

NCT04322188

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: ASST - Papa Giovanni XXIII Bergamo, Italy

View Trial Details